Transitional cell carcinoma of the bladder is comprised of a variety of cancer diatheses that manifest a spectrum of distinct biologic potentials. The challenge is to control superficial disease recurrence and progression and to identify invasive carcinoma at an earlier stage, when it may be more amenable to cure.
No takes yet. Share an insight, caveat, or question.
Hassen et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: